28 November 2022
Hogan Lovells advises CatalYm on €50m Series-C financing round
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Dr Nikolas Zirngibl Lead | Hogan Lovells Cadwalader | Partner | Corporate/ Venture Capital | Munich |
| Thiemo Woertge | Hogan Lovells Cadwalader | Senior associate | Corporate/ Venture Capital | Munich |
| Dr Kilian Pfahl | Hogan Lovells Cadwalader | Associate | Corporate/ Venture Capital | Munich |
| Arne Thiermann | Hogan Lovells Cadwalader | Partner | Strategic Operations Agreement Regulations/ Life Sciences | Hamburg |
| Karolin Hiller | Hogan Lovells Cadwalader | Senior associate | Strategic Operations Agreement Regulations/ Life Sciences | Berlin |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 50m (€50 million)
- What the figure measures
- Fund size
- Client
- CatalYm GmbHIssuer
- Counterparties
- Brandon Capital (Investor)
Jeito Capital (Investor)
Forbion (Investor)
Novartis Venture Fund (Investor)
Vesalius Biocapital III (Investor)
Bayern Kapital (Investor)
BioGeneration Ventures (Investor)
Coparion (Investor)